ALAN J REIS, M.D.
Psychiatric at Northgate Sq, Greensburg, PA
License number
Pennsylvania MD067424L
Category
Psychiatric
Type
Psychiatry
Address
Address
2
1 Northgate Sq, Greensburg, PA 15601
540 N Neville St SUITE 104, Pittsburgh, PA 15213
540 N Neville St SUITE 104, Pittsburgh, PA 15213
Phone
(724) 832-1666
(412) 918-2334 (Fax)
(412) 682-3003
(412) 918-2334 (Fax)
(412) 682-3003
Personal information
See more information about ALAN J REIS at radaris.comName
Address
Phone
524 4Th St, Monongahela, PA 15063
230 Craig St, Pittsburgh, PA 15213
524 4Th St, Monongahela, PA 15063
524 4Th St, Monongahela, PA 15063
5107 Ellsworth Ave, Pittsburgh, PA 15232
Organization information
See more information about ALAN J REIS at bizstanding.comAlan J Reis MD
540 Neville Rd, Pittsburgh, PA 15225
Categories:
Group Medical Practice
Phone:
(412) 918-1812 (Phone)
Professional information
Dr. Alan J Reis, Pittsburgh PA - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Psychiatry)
Address:
Alan J Reis MD
540 N Neville St SUITE 104, Pittsburgh 15213
(412) 687-0700 (Phone)
540 N Neville St SUITE 104, Pittsburgh 15213
(412) 687-0700 (Phone)
Certifications:
Psychiatry, 2000
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Rosalind Franklin University of Medicine and Science / Chicago Medical School
Graduated: 1995
Rosalind Franklin University of Medicine and Science / Chicago Medical School
Graduated: 1995
Registry Method And Control System For Dea Schedule Ii-V Medicines
US Patent:
2009020, Aug 20, 2009
Filed:
Feb 23, 2006
Appl. No.:
11/922794
Inventors:
Alan J Reis - Pittsburgh PA, US
Christian Schafmeister - Pittsburgh PA, US
Christian Schafmeister - Pittsburgh PA, US
International Classification:
A61K 51/00, C07D 243/14, C07C 211/01, C07C 209/44, C07D 211/32, C07D 489/00, C07D 211/58, C07C 215/42, C07D 471/04, C12Q 1/02
US Classification:
424 181, 540570, 564374, 564375, 546248, 546 44, 564316, 546244, 564443, 546121, 435 29
Abstract:
The present invention provides compositions and methods for synthesizing labeled drugs. The present invention further provides methods for preventing or stopping prescription drug abuse for all agents registered as a Drug Enforcement Agency (DEA) schedule II through schedule V medications. According to the present invention, methods are provided for monitoring patient compliance with prescribed drug treatment. The present invention also provides methods for facilitating a replacement prescription when a patient is left without access to their prescribed drug. Furthermore, the present invention provides a method to improve employee compliance with an employer's drug policies via either a voluntary or compulsory system for enhanced drug testing.